Epirubicin and interstitial lung disease Patient Reports February 12, 2012

Epirubicin Side Effects Report #5389598-7
Epirubicin side effect was reported by a Health Professional from UNITED KINGDOM on July 06, 2007. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease. Epirubicin dosage: unknown. During the same period patient was treated with CARBOPLATIN, VINCRISTINE, ETOPOSIDE, IFOSFAMIDE, ACTINOMYCIN D. Patient died.

Epirubicin Side Effects Report #5277935-3
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 15, 2007. Male patient was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease. Epirubicin dosage: DAILY DOSE:150MG/M*2. During the same period patient was treated with VINCRISTINE SULPHATE. Patient died.

Epirubicin Side Effects Report #5320655-7
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 27, 2007. Male patient was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease. Epirubicin dosage: DAILY DOSE:150MG/M*2. During the same period patient was treated with CARBOPLATIN, VINCRISTINE SULPHATE, ETOPOSIDE, IFOSFAMIDE, DACTINOMYCIN. Patient died.

Epirubicin Side Effects Report #5342511-0
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 21, 2007. Male patient was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: febrile neutropenia, interstitial lung disease, ototoxicity, recall phenomenon, respiratory failure. Epirubicin dosage: DAILY DOSE:150MG/M*2. During the same period patient was treated with CARBOPLATIN, VINCRISTINE SULPHATE, ETOPOSIDE, IFOSFAMIDE, DACTINOMYCIN. Patient died.


Epirubicin Side Effects Report #5362641-7
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 07, 2007. Male patient was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: febrile neutropenia, interstitial lung disease, ototoxicity, recall phenomenon, respiratory failure. Epirubicin dosage: DAILY DOSE:150MG/M*2. During the same period patient was treated with CARBOPLATIN, VINCRISTINE SULPHATE, ETOPOSIDE, IFOSFAMIDE, DACTINOMYCIN. Patient died.

Epirubicin Side Effects Report #5375325-6
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 18, 2007. Male patient was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: febrile neutropenia, interstitial lung disease, ototoxicity, recall phenomenon, respiratory failure. Epirubicin dosage: DAILY DOSE:150MG/M*2. During the same period patient was treated with CARBOPLATIN, VINCRISTINE SULPHATE, ETOPOSIDE, IFOSFAMIDE, DACTINOMYCIN. Patient was hospitalized. Patient died.

Epirubicin Side Effects Report #5403231-7
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 20, 2007. Male patient was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: febrile neutropenia, interstitial lung disease, ototoxicity, recall phenomenon, respiratory failure. Epirubicin dosage: DAILY DOSE:150MG/M*2. During the same period patient was treated with CARBOPLATIN, VINCRISTINE SULPHATE, ETOPOSIDE, IFOSFAMIDE, DACTINOMYCIN. Patient was hospitalized. Patient died.

Epirubicin Side Effects Report #5633443-9
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 11, 2008. Male patient was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: febrile neutropenia, interstitial lung disease, ototoxicity, recall phenomenon, respiratory failure. Epirubicin dosage: DAILY DOSE:150MG/M*2. During the same period patient was treated with CARBOPLATIN, VINCRISTINE SULPHATE, ETOPOSIDE, IFOSFAMIDE, DACTINOMYCIN. Patient was hospitalized. Patient died.

Epirubicin Side Effects Report #4837940-5
Epirubicin side effect was reported by a Physician from JAPAN on Nov 10, 2005. Male patient, 60 years of age, was diagnosed with ill-defined disorder and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease. Epirubicin dosage: 40 MG,. Patient recovered.


Epirubicin Side Effects Report #5961127-6
Epirubicin side effect was reported by a Physician from ITALY on Nov 07, 2008. Male patient, 68 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease, mucosal inflammation, neutropenia. Epirubicin dosage: unknown. During the same period patient was treated with ETOPOSIDE, VINCRISTINE, BLEOMYCIN SULPHATE, PREDNISONE, CYCLOPHOSPHAMIDE, IMMUNOSUPPRESSANTS, FLUCONAZOLE. Patient died.

Epirubicin Side Effects Report #6055743-3
Epirubicin side effect was reported by a Physician from ITALY on Jan 12, 2009. Male patient, 68 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease, mucosal inflammation, neutropenia. Epirubicin dosage: unknown. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient died.

Epirubicin Side Effects Report #5161761-X
Epirubicin side effect was reported by a Physician from JAPAN on Nov 09, 2006. Female patient, 65 years of age, weighting 132.3 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease, lymphocyte stimulation test positive. Epirubicin dosage: 110 MG (110 MG, 1 IN 1 D). During the same period patient was treated with FLUOROURACIL, CYCLOPHOSPHAMIDE, PAXIL, DEPROMEL, FLUMEZIN, ARTANE, LORAZEPAM, ARICEPT. Patient was hospitalized and became disabled. Patient recovered.

Epirubicin Side Effects Report #5094013-7
Epirubicin side effect was reported by a Physician from JAPAN on Aug 16, 2006. Female patient, 64 years of age, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease, lymphocyte stimulation test positive. Epirubicin dosage: unknown. During the same period patient was treated with FLUOROURACIL, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5971323-X
Epirubicin side effect was reported by a Consumer or non-health professional from JAPAN on Nov 20, 2008. Female patient, 63 years of age, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease. Epirubicin dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUOROURACIL. Patient recovered.


Epirubicin Side Effects Report #5971322-8
Epirubicin side effect was reported by a Consumer or non-health professional from JAPAN on Nov 20, 2008. Female patient, 62 years of age, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease. Epirubicin dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUOROURACIL. Patient recovered.

Epirubicin Side Effects Report #5053799-8
Epirubicin side effect was reported by a Physician from JAPAN on June 28, 2006. Female patient, 60 years of age, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease. Epirubicin dosage: 60 MG/M*2, INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, CYCLOPHOSPHAMIDE. Patient recovered.

Epirubicin Side Effects Report #5104079-3
Epirubicin side effect was reported by a Physician from JAPAN on Aug 29, 2006. Female patient, 60 years of age, weighting 114.6 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease, lung disorder, neutrophil count decreased, white blood cell count decreased. Epirubicin dosage: 90 MG (90 MG, FREQUENCY: QD) INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, CYCLOPHOSPHAMIDE. Patient recovered.

Epirubicin Side Effects Report #5170628-2
Epirubicin side effect was reported by a Physician from JAPAN on Nov 20, 2006. Female patient, 59 years of age, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: hepatic function abnormal, interstitial lung disease, vasculitis , white blood cell count decreased. Epirubicin dosage: 25 MG MG/M*2 (WEEKLY). During the same period patient was treated with DOCETAXEL. Patient recovered.

Epirubicin Side Effects Report #4989059-0
Epirubicin side effect was reported by a Health Professional from JAPAN on Apr 13, 2006. Female patient, 58 years of age, weighting 120.8 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease. Epirubicin dosage: 120 MG (1 IN 1 D), INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUOROURACIL, NORVASC, OXYCONTIN, DEPAS, FAMOTIDINE, PACLITAXEL. Patient was hospitalized. Patient recovered.


Epirubicin Side Effects Report #5971318-6
Epirubicin side effect was reported by a Consumer or non-health professional from JAPAN on Nov 20, 2008. Female patient, 56 years of age, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease. Epirubicin dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUOROURACIL, DOCETAXEL. Patient recovered.

Epirubicin Side Effects Report #5062915-3
Epirubicin side effect was reported by a Physician from JAPAN on July 10, 2006. Female patient, 55 years of age, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease. Epirubicin dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5072960-X
Epirubicin side effect was reported by a Physician from JAPAN on July 20, 2006. Female patient, 55 years of age, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease. Epirubicin dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #4585613-9
Epirubicin side effect was reported by a Physician from on Feb 03, 2005. Female patient, 54 years of age, weighting 112.4 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: blood beta-d-glucan increased, infection , interstitial lung disease. Epirubicin dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DEXAMETHASONE, GRANISETRON, LAFUTIDINE, LORAZEPAM, PROCHLORPERAZINE, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #4849583-8
Epirubicin side effect was reported by a Physician from JAPAN on Sept 01, 2005. Female patient, 54 years of age, weighting 112.4 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: blood beta-d-glucan increased, infection , interstitial lung disease. Epirubicin dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DECADRON, KYTRIL, LAFUTIDINE, LORAZEPAM, NOVAMIN, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.


Epirubicin Side Effects Report #5223018-8
Epirubicin side effect was reported by a Consumer or non-health professional from JAPAN on Jan 17, 2007. Female patient, weighting 112.4 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: hepatic function abnormal, interstitial lung disease, pyrexia, vasculitis , white blood cell count decreased. Epirubicin dosage: DAILY DOSE:39MG-FREQ:DAILY. During the same period patient was treated with TAXOTERE, TAMOXIFEN CITRATE. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5267710-8
Epirubicin side effect was reported by a Consumer or non-health professional from JAPAN on Mar 06, 2007. Female patient, weighting 112.4 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: hepatic function abnormal, interstitial lung disease, pyrexia, vasculitis , white blood cell count decreased. Epirubicin dosage: DAILY DOSE:39MG. During the same period patient was treated with TAXOTERE, TAMOXIFEN CITRATE. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5579754-7
Epirubicin side effect was reported by a Physician from JAPAN on Dec 21, 2007. Female patient, weighting 105.8 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease. Epirubicin dosage: unknown. During the same period patient was treated with ENDOXAN, NASEA, DECADRON, RINDERON. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5625160-6
Epirubicin side effect was reported by a Physician from JAPAN on Feb 05, 2008. Female patient, weighting 149.9 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease. Epirubicin dosage: DAILY DOSE:100MG. During the same period patient was treated with ENDOXAN, NAVOBAN, DEXAMETHASONE PHOSPHATE, DEXAMETHASONE PHOSPHATE, NAUZELIN, KYTRIL. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5651792-5
Epirubicin side effect was reported by a Physician from JAPAN on Feb 22, 2008. Female patient, weighting 149.9 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease. Epirubicin dosage: DAILY DOSE:100MG. During the same period patient was treated with ENDOXAN, NAVOBAN, DEXAMETHASONE PHOSPHATE, DEXAMETHASONE PHOSPHATE, NAUZELIN, KYTRIL. Patient was hospitalized. Patient recovered.


Epirubicin Side Effects Report #5543077-2
Epirubicin side effect was reported by a Physician from JAPAN on Nov 28, 2007. Male patient, 76 years of age, was diagnosed with bladder cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease. Epirubicin dosage: unknown. During the same period patient was treated with FOSAMAX, TAKEPRON, IMURAN, MUCODYNE, MEDICON, HOKUNALIN, HYPEN. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5606754-0
Epirubicin side effect was reported by a Physician from JAPAN on Jan 21, 2008. Male patient, weighting 134.5 lb, was diagnosed with bladder cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease. Epirubicin dosage: unknown. During the same period patient was treated with FOSAMAX, TAKEPRON, IMURAN, MUCODYNE, MEDICON, HOKUNALIN, HYPEN, NITRODERM. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5657357-3
Epirubicin side effect was reported by a Physician from JAPAN on Feb 27, 2008. Male patient, weighting 134.5 lb, was diagnosed with bladder cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease. Epirubicin dosage: unknown. During the same period patient was treated with FOSAMAX, TAKEPRON, IMURAN, MUCODYNE, MEDICON, HOKUNALIN, HYPEN, NITRODERM. Patient was hospitalized. Patient recovered.